| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the Department of Physiology (F.H., J.B., S.D., D.M.B.), Loyola University Chicago, Maywood, Ill; and University of Virginia (A.L.T.), Charlottesville, Va.
Correspondence to Donald M. Bers, PhD, Department of Physiology, Loyola University Chicago, Stritch School of Medicine, 2160 S First Ave, Maywood, IL 60153. E-mail dbers{at}lumc.edu
Because phospholemman (PLM) regulates the Na+/K+ pump (NKA) and is a major cardiac phosphorylation target for both protein kinase A (at Ser68) and protein kinase C (PKC) (at both Ser63 and Ser68), we evaluated whether PLM mediates the PKC-dependent regulation of NKA function and protein kinase A/PKC crosstalk in ventricular myocytes. PKC was activated by PDBu (300 nmol/L), and we measured NKA-mediated [Na+]i decline (fluorescence measurements) and current (Ipump) (voltage clamp). In wild-type mouse myocytes, PDBu increased PLM phosphorylation at Ser63 and Ser68, Ipump (both at 10 and 100 mmol/L Na+ in the pipette solution) and maximal NKA-mediated Na+ extrusion rate (Vmax) from 7.9±1.1 to 12.7±1.9 mmol·L1 per minute without altering NKA affinity for internal Na+ (K0.5). In PLM knockout mice, PDBu had no effect on either Vmax or K0.5. After pretreatment with isoproterenol (ISO) (1 µmol/L), PDBu still increased the NKA Vmax and PLM phosphorylation at Ser63 and Ser68. Conversely, after pretreatment with PDBu, ISO further increased the Na+ affinity of NKA and phosphorylation at Ser68, as it did alone without PDBu. The final NKA activity was independent of the application sequence. The NKA activity in PLM knockout myocytes, after normalizing the protein level, was similar to that after PDBu and ISO treatment. We conclude that (1) PLM mediates the PKC-dependent activation of NKA function in cardiac myocytes, (2) PDBu and ISO effects are additive in the mouse (affecting mainly Vmax and K0.5, respectively), and (3) PDBu and ISO combine to activate NKA in wild-type to the level found in the PLM knockout mouse.
Key Words: Na+ pump phospholemman PKA PKC
Related Article:
Circ. Res. 2006 99: 1290-1292.
This article has been cited by other articles:
![]() |
S. Despa, A. L. Tucker, and D. M. Bers Phospholemman-Mediated Activation of Na/K-ATPase Limits [Na]i and Inotropic State During {beta}-Adrenergic Stimulation in Mouse Ventricular Myocytes Circulation, April 8, 2008; 117(14): 1849 - 1855. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Bell, E. Kennington, W. Fuller, K. Dighe, P. Donoghue, J. E. Clark, L.-G. Jia, A. L. Tucker, J. Randall Moorman, M. S. Marber, et al. Characterization of the phospholemman knockout mouse heart: depressed left ventricular function with increased Na-K-ATPase activity Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H613 - H621. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Cheung Regulation of cardiac contractility: high time for FXYD Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H584 - H585. [Full Text] [PDF] |
||||
![]() |
S. Bibert, S. Roy, D. Schaer, J.-D. Horisberger, and K. Geering Phosphorylation of Phospholemman (FXYD1) by Protein Kinases A and C Modulates Distinct Na,K-ATPase Isozymes J. Biol. Chem., January 4, 2008; 283(1): 476 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Fuller and M. J. Shattock Phospholemman and the Cardiac Sodium Pump: Protein Kinase C, Take a Bow Circ. Res., December 8, 2006; 99(12): 1290 - 1292. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |